ICG wins ‘attractive’ IRR and money multiple with Amolyt sale

ICG invested in Amolyt in January 2023, co-leading the series C round.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this